Selection from HEOR Bibliography

IMS logo
Search criteria
Country: China
 
Cost-effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China
Authors: Ahmed Salem 1, Peng Men 2 3, Mafalda Ramos 4, Yan-Jun Zhang 5, Anastasia Ustyugova 6, Mark Lamotte 7
Affiliations: 1IQVIA, Real World Solutions, Zaventem 1930, Belgium. 2Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China. 3Institute for Drug Evaluation, Peking University Health Science Center, Beijing 100191, China. 4IQVIA, Global HEOR, Porto Salvo 2740-266, Portugal. 5Boehringer Ingelheim, Health Economics & Outcomes Research, Government Affairs & Market Access, Shanghai 200040, China. 6Boehringer Ingelheim, CardioMetabolism Respiratory, Ingelheim am Rhein 55216, Germany. 7IQVIA, Global HEOR, Zaventem 1930, Belgium.
Publications: 
Journal of Comparative Effectiveness Research 2021 https://doi.org/10.2217/cer-2020-0284.
PMID: 33576249 DOI: 10.2217/cer-2020-0284
Document Types: , Article
Countries: , China
Abstract: https://pubmed.ncbi.nlm.nih.gov/33576249/
Condition Year Language Analysis type
, Diabetes, Health economics 2021 English , Clinical setting: Primary care, Cost effectiveness
 
 
Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China
Authors: Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
Affiliations: 1Real World Evidence, IQVIA, Zaventem, Belgium. 2R&D China, AstraZeneca R&D, Shanghai, China. 3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo. #Contributed equally.
Publications: 
BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664
e043664. doi:10.1136/bmjopen-2020-043664
PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
Document Types: , Article
Countries: , Belgium, China
Abstract: https://pubmed.ncbi.nlm.nih.gov/33910947/
Condition Year Language Analysis type
, Health economics, Respiratory disease 2021 English , Clinical setting: Primary care, Cost effectiveness
 
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Authors: Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publications: 
IPVC, Barcelona, Spain, 23-27 March 2020
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Portugal, Spain
Condition Year Language Analysis type
, Infectious disease, Oncology 2020 English , Burden of illness, Observational study, Retrospective Field Study
 
 
Projected long-term clinical benefit and cost-effectiveness of empagliflozin compared to glimepiride in patients with type 2 diabetes in China
Authors: Lamotte M1, Salem A2, Mettam S2, Ustyugova A2, Zhang YJ3, Ramos M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 Boehringer Ingelheim International, GmbH, Germany 3 Boehringer Ingelheim, Beijing, China
Publications: 
ADA, San Francisco, US, 07-11 June 2019
Document Types: , Poster
Countries: , China
Abstract: https://doi.org/10.2337/db19-1292-P
Condition Year Language Analysis type
, Diabetes 2019 English , Cost effectiveness, Population Based Study
 
 
Contrasting three type 2 diabetes cardiovascular risk equations for East Asia with UKPDS82 using the IQIVA core diabetes model
Authors: Olivieri A1, Ramos M2, Monteiro S3, Altrabsheh E3, Gurjar K4, Lamotte M2
Affiliations: 1 IQVIA, Basel, Switzerland 2 IQVIA, Zaventem, Belgium 3 IQVIA, London, UK 4 IQVIA, Gurgaon, India
Publications: 
ISPOR, New Orleans, 18-22 May 2019
Document Types: , Poster
Countries: , China
Condition Year Language Analysis type
, Diabetes 2019 English , Cost effectiveness, Population Based Study
 
 
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY
Authors: Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US
Publications: 
EUROGIN, Monaco, France, 4-7 December 2019
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Spain, UK, USA
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf
Condition Year Language Analysis type
, Clinical practice, Infectious disease, Methodology 2019 English , Epidemiological study, Observational study, Population Based Study
 
 
Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach
Authors: Foos V1, Wang K2, McEwan P3, Zhang Y2, Xin P2, Jiang X2, Qu S4, Xiong T4, De Moor R1, Ramos M1, Lamotte M1, Ji L5
Affiliations: 1 IQVIA, Zaventem, Belgium 2 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai, China 3 Centre for Health Economics, Swansea University, Wales, England, UK 4 RWE Solutions & HEOR, QuintilesIMS, Shanghai, China 5 Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China
Publications: 
Value Health Reg Issues. 2019 May;18:36-46.
Document Types: , Article
Countries: , China
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30419449
Condition Year Language Analysis type
, Diabetes, Health economics 2019 English , Cost effectiveness
 
 
Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for systemic candida infections in China
Authors: Dechang Chen, Xianyao Wan, Eliza Kruger, Can Chen, Xiaomeng Yue, Liang Wang, Jiuhong Wu
Affiliations: IQVIA, Department of Critical Care Medicine, Shanghai Ruijin Hospital Affiliated To Jiaotong University, School of Medicine, Shanghai
Publications: 
Journal of Medical Economics
Document Types: , Article
Countries: , China
Abstract: http://www.tandfonline.com/doi/abs/10.1080/13696998.2017.1417312
Condition Year Language Analysis type
, Health economics, Infectious disease 2018 English , Cost effectiveness
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications: 
Document Types: 
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition Year Language Analysis type
2018 English
 
 
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries
Authors: Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition Year Language Analysis type
, Oncology 2018 English
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Authors: Salem A1, Ramos M1, Hu H2, Zhong H3, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 University of Macau, Macau, China 3 AstraZeneca, Shanghai, China
Publications: 
Document Types: , Poster
Countries: , China
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/83455
Condition Year Language Analysis type
, Health economics, Respiratory disease 2018 English , Cost analysis, Cost effectiveness
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Authors: Salem A, Ramos M, Hu H, Zhong H, Lamotte M
Affiliations: IQVIA, Zaventem, Belgium
Publications: 
ISPOR Asia Pacific, 2018, September 8-11, Tokyo, Japan
Document Types: , Poster
Countries: , China
Condition Year Language Analysis type
, Health economics, Respiratory disease 2018 English , Cost effectiveness
 
 
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis
Authors:  Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Initial Management of localised prostate cancer in the Elderly: An International Data Review
Authors: Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: 
SIOG 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications: 
JCO ( ASCO 2018)
Document Types: , Abstract
Countries: , Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Assessing the economic burden of type 2 diabetes in China reflecting the current standard of the disease management and for improved management scenarios using a modeling approach.
Authors: Foos V1, Lamotte M1, McEwan P4, Jiang X3, Zhang YL3, Qu S2, De Moor R1, Ramos R1, Xiong T2, Wang K3
Affiliations: 1 IMS Health, Brussels, Belgium 2 IMS Health, Shanghai, China 3 Eli Lilly, Shanghai, China 4 Swansea University, Wales
Publications: 
22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA
Document Types: , Abstract
Countries: , China
Condition Year Language Analysis type
, Diabetes 2017 English , Cost effectiveness
 
 
THE ANALYSIS OF INPATIENTS COST OF BREAST CANCER IN CHINA, 2011
Authors: Song S, Wang Z, Zhang M
Affiliations: IMS consulting group, Shanghai, China
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , China
Condition Year Language Analysis type
, Mental health, Oncology 2015 English
 
 
Cost-Effectiveness of Linezolid versus Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Confirmed Nosocomial Pneumonia in China
Authors: Tan S1, Wang X2, Wu B3, Kang H4, Li Q5, Chen Y6, Chen C6, Hajek P7, Patel D8, Gao X8
Affiliations: 1IMS Health, Singapore
Publications: 
Value in Health, Volume 3, May 2014, Pages 94–100
Document Types: , Article
Countries: , China
Abstract: http://www.sciencedirect.com/science/article/pii/S221210991400017X
Condition Year Language Analysis type
, Respiratory disease 2014 English , Cost effectiveness
 
 
HTA, budget impact tools and international price referencing from China’s perspective: what are the current developments and future considerations?
Authors: Koh L1, Li SC2, Zhang M3, Glaetzer C1
Affiliations: 1 Johnson & Johnson, Singapore, Singapore 2 School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia 3 IMS Consulting, Shanghai, China
Publications: 
ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
Document Types: , Panel presentation
Countries: , China
Condition Year Language Analysis type
, Pricing and reimbursement 2014 English , Pricing & Reimbursement
 
 
Afatinib in the treatment of EGFR mutation-positive NSCLC - A network meta-analysis.
Authors: Popat S1, Mok T2, Yang JC3, Wu YL4, Lungershausen J5, Stammberger U5, Griebsch I5, Fonseca T6, Paz-Ares L7
Affiliations: 1Royal Marsden Hospital, London, UK. 2State Key Laboratory of Southern China, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong. 3National Taiwan University, Taipei, Taiwan. 4Guangdong Lung Cancer Institute, Guangzhou, China. 5Boehringer Ingelheim GmbH, Ingelheim, Germany. 6IMS Health, London, UK. 7Instituto de Biomedicina de Sevilla - IBIS (University Hospital Virgen del Rocío, US, CSIC), Seville, Spain.
Publications: 
Lung Cancer. 2014 Aug;85(2):230-8
Document Types: , Article
Countries: , China, Germany, Hong Kong, Spain, Taiwan, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24929780
Condition Year Language Analysis type
, Oncology 2014 English , Meta analysis
 
 
Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext
Condition Year Language Analysis type
, Oncology 2013 English , Retrospective database analysis
 
 
Current situation of oral anticancer treatments use in France: the ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Abstract
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext
Condition Year Language Analysis type
, Oncology 2013 English
 
 
Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries.
Authors: Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations: 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publications: 
5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Types: , Abstract, Poster
Countries: , Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand
Condition Year Language Analysis type
, Ophthalmology 2012 English , Burden of illness
 
 
Direct medical costs of Diabetes Mellitus in China: Annual cost of illness and long-term projections using a validated diabetes model
Authors: Palmer JL1, Caputo J2, Foos V1, Grant D3, Lamotte M4, Lloyd A3, McEwan P5
Affiliations: 1 IMS Health, Basel, Switzerland, 2 IMS Health, Singapore, Singapore, 3 IMS Health, London, UK, 4 IMS Health Consulting Group, Vilvoorde, Belgium, 5 HEOR Consulting, Monmouth, Monmouthshire, UK
Publications: 
ISPOR 5th Asia-Pacific Conference, Taipei, Taiwan, September 2nd – 4th 2012
Document Types: , Poster
Countries: , China
Abstract: http://www.ispor.org/conferences/Taipei0912/Posters2.aspx
Condition Year Language Analysis type
, Diabetes 2012 English , Cost of illness
 
 
Usage of Self-Monitoring of Blood Glucose (SMBG) by Diabetes Therapy Type in Larger Cities in China.
Authors: Mast O1, Tan A2, Zweyer S2, Perridy D2.
Affiliations: 1Roche, Mannheim, Germany 2Cegedim Strategic Data, Shanghai, China
Publications: 
ISPOR 5TH ASIA-PACIFIC CONFERENCE , TAIPEI, TAIWAN
Document Types: , Poster
Countries: , China
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)01865-7/abstract
Condition Year Language Analysis type
, Diabetes 2012 English , Compliance, Retrospective database analysis
 
 
UTILIZATION OF FPG, HBA1C AND SELF-MONITORING OF BLOOD GLUCOSE (SMBG) IN COMMUNITY HEALTH CENTERS IN THE SHANGHAI AREA.
Authors: Mast O1, Tan A2
Affiliations: 1Roche, Mannheim, Germany 2Cegedim Strategic Data, Shanghai, China
Publications: 
ISPOR 5TH ASIA-PACIFIC CONFERENCE, TAIPEI, TAIWAN
Document Types: , Poster
Countries: , China
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)01866-9/abstract
Condition Year Language Analysis type
, Diabetes 2012 English , Compliance, Survey research
 
 
Real World Patient Profile of Patients with Reduced Ejection Fraction Heart Failure (HF-REF) in 5 Regions of China.
Authors: Li XY, Crawford B, Liao YH, Tanaka E, Wang D, Sung J, Zheng J, McDonald J.
Affiliations: 
Publications: 
ISPOR (June 2 – 6, 2012, Washington DC
Document Types: , Poster
Countries: , China
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)00765-6/abstract
Condition Year Language Analysis type
, Cardiovascular disease 2012 English
 
 
Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma.
Authors: Chen M1, Therneau T, Orsini LS, Qiao YL.
Affiliations: Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangdong Province, China
Publications: 
BMC Gastroenterol. 2011 May 12;11:53
Document Types: , Article
Countries: , China
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115904/
Condition Year Language Analysis type
, Oncology 2011 English , Clinical setting: hospital, Retrospective cohort analysis
 
 
Clinical and cost effectiveness of biphasic insulin aspart 30 once or twice daily versus insulin glargine in type 2 diabetes mellitus: a modeling analysis in the Chinese setting
Authors: Palmer JL1, Beaudet A1, White,J2, Plun-Favreau J3,Smith-Palmer J1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk I/O, Zurich, Switzerland; 3 Novo Nordisk A/S, Copenhagen, Denmark
Publications: 
ISPOR 4th Asia-Pacific Conference, 5-7 September 2010, Hilton Phuket, Phuket, Thailand
Document Types: , Poster
Countries: , China
Abstract: http://www.ispor.org/conferences/Phuket0910/posters.aspx
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Cost-Effectiveness of Biphasic Insulin Aspart versus Insulin Glargine in Patients with Type 2 Diabetes in China
Authors: Palmer JL1, Beaudet A1, White J2, Plun-Favreau J3, Smith‑Palmer J1
Affiliations: 1 IMS Health, Theaterstrasse 4, 4051, Basel, Switzerland 2 Novo Nordisk I/O, Zurich, Switzerland 3 Novo Nordisk A/S, Copenhagen, Denmark
Publications: 
Adv Ther. 2010 Nov;27(11):814-27
Document Types: , Manuscript in preparation
Countries: , China
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21061114
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Cost-Effectiveness of Switching to Biphasic Insulin Aspart in Poorly-Controlled Type 2 Diabetes Patients in China
Authors: Palmer JL1, Gibbs M2, Scheijbeler H3, Kotchie R3, Nielsen S4, White J5, Valentine WJ1
Affiliations: 1IMS Health, Basel, Switzerland, 2IMS Health, Shanghai, China, 3IMS Health, London, UK, 4Novo Nordisk A/S, Bagsværd, Denmark, 5Novo Nordisk International Operations A/S, Zurich, Switzerland
Publications: 
Adv Ther. 2008 Aug;25(8):752-74.
Document Types: , Article
Countries: , China
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analyses in a Chinese setting.
Authors: Chen X1, Clegg JP2, Chen L1, Yu H3, Wittrup-Jensen KU4, Valentine WJ1
Affiliations: 1Fu Dan University, Shanghai, China, 2IMS Health, Basel, Switzerland, 3Bayer Healthcare Co. Ltd, Shanghai, China, 4Bayer Schering Pharma AG, Berlin, Germany
Publications: 
3rd Asia-Pacific Conference, 7-9 September 2008
Document Types: , Oral presentation
Countries: , China
Abstract: http://www.ingentaconnect.com/content/apl/cmro/2006/00000022/00000007/art00019?token=006718db3e1a03ae72752d455e4e2663433b393f6a3340257d7241255e437a63736a425b6b674c58662a702c2e6e49625371e31
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Cost-effectiveness of biphasic insulin aspart 30 versus human premix insulin for type 2 diabetes patients in China
Authors: Lynch M1, Scheijbeler HW2, Kotchie R2, Valentine WJ3, Nielsen S4, White J5
Affiliations: 1IMS Health, Shanghai, China; 2IMS Health, London, UK; 3 IMS Health, Basel, Switzerland; 4Novo Nordisk, Bagsværd, Denmark; 5Novo Nordisk, Zürich, Switzerland
Publications: 
ISPOR 2007 10th Annual European Congress, Athens, Greece, 8 – 11 November 2008
Document Types: , Poster
Countries: , China
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Asthma control and its direct healthcare costs: findings using a derived Asthma Control Test (ACT) score in eight Asia-Pacific areas.
Authors: Lai CKW1 Kuo S-H2 de Guia T3 Lloyd A4, Williams AE5, Spencer MD5
Affiliations: 1 Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong 2 National Taiwan University Hospital, Taipei, Taiwan 3 Philippine Heart Centre, Quezon City, The Philippines 4 Fourth Hurdle Consulting Ltd, London, UK 5 GlaxoSmithKine R&D, Greenford, UK
Publications: 
European Respiratory Review 2006; 15:(98): 24-29
Document Types: , Manuscript in preparation
Countries: , China, Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Vietnam
Condition Year Language Analysis type
, Respiratory disease 2006 English , Cost of illness
 
 
Potential savings with everolimus with reduced-dose cyclosporine compared to mycophenolate motefil with full dose cyclosporine in de novo renal transplant recipients in China.
Authors: Yang X, Ethgen O, Wang W, Lian R, Ricci JF, Spaepen E et al.
Affiliations: 
Publications: 
ISPOR 2nd Asia-Pacific Congress, Shanghai, China
Document Types: , Poster
Countries: , China
Condition Year Language Analysis type
, Nephrology 2006 English
 
 
Copyright © 2024 IMS Health Incorporated. All rights reserved.